SEKIX
Price
$17.82
Change
-$0.27 (-1.49%)
Updated
Sep 6 closing price
VEIEX
Price
$27.63
Change
-$0.39 (-1.39%)
Updated
Sep 6 closing price
Ad is loading...

SEKIX vs VEIEX

Header iconSEKIX vs VEIEX Comparison
Open Charts SEKIX vs VEIEXBanner chart's image
DWS Emerging Markets Equity Inst
Price$17.82
Change-$0.27 (-1.49%)
VolumeN/A
CapitalizationN/A
Vanguard Emerging Mkts Stock Idx I
Price$27.63
Change-$0.39 (-1.39%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
SEKIX vs VEIEX Comparison Chart
Loading...
VS
SEKIX vs. VEIEX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SEKIX is a StrongBuy and VEIEX is a Buy.

FUNDAMENTALS
Fundamentals
VEIEX has more cash in the bank: 108B vs. SEKIX (65.2M). VEIEX pays higher dividends than SEKIX: VEIEX (3.27) vs SEKIX (2.18). SEKIX was incepted earlier than VEIEX: SEKIX (17 years) vs VEIEX (30 years). SEKIX is a more actively managed with annual turnover of: 64.00 vs. VEIEX (5.00). VEIEX has a lower initial minimum investment than SEKIX: VEIEX (0) vs SEKIX (1000000). SEKIX (11.75) and VEIEX (11.44) have marching annual gain over last year. VEIEX return over 5 years is better than : 16.99 vs. SEKIX (3.78).
SEKIXVEIEXSEKIX / VEIEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years30 years-
Gain YTD6.0387.87777%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets65.2M108B0%
Annual Yield % from dividends2.183.2767%
Returns for 1 year11.7511.44103%
Returns for 3 years-19.82-10.67186%
Returns for 5 years3.7816.9922%
Returns for 10 years15.4512.90120%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATS25.550.42
+1.67%
ATS Corp
VRSN183.56-1.33
-0.72%
VeriSign
AMTB20.98-0.24
-1.13%
Amerant Bancorp
TLYS4.75-0.19
-3.85%
Tilly's
MIRA1.58-0.12
-7.06%
MIRA Pharmaceuticals